Argan (NYSE: AGX) traded higher Tuesday, up 3.36% to $720.38, with the most recent identifiable catalyst still tied to its stepped-up capital return framework. The company disclosed that its board increased the share repurchase authorization to $200 million (from $150 million) and extended the program’s expiration through January 31, 2030, alongside declaring a regular quarterly cash dividend of $0.50 per share.

A larger buyback authorization can tighten effective float over time and signal management confidence in cash generation, which can support price action even without a same-day earnings release or contract headline. With AGX already in a strong momentum regime, incremental shareholder-return commitments can act as a continuing bid, particularly when traders look for a clear, company-specific reason behind a modest single-day move.

Investors will focus on any incremental updates to backlog, notices to proceed, or new EPC awards from Gemma Power Systems, since project timing and conversion into revenue and margins are key drivers for the stock. Separately, any disclosure around repurchase pacing (how much has been used, and at what price) could influence near-term trading as the market gauges how much demand the buyback might add versus valuation and liquidity.